Diagnostics and therapeutics: the CRISPR story continues

The last time The Lancet Microbe featured an Editorial on CRISPR was in November 2020, to mark that year’s Nobel Prize in Chemistry, jointly awarded to Emmanuelle Charpentier and Jennifer A Doudna for their work developing CRISPR-Cas9 genome editing technology.

Authors

Publication Details

Journal
The Lancet Microbe
Published
2026-04-01
DOI
https://doi.org/10.1016/j.lanmic.2026.101417
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostics and therapeutics: the CRISPR story continues

The Lancet Microbe
The Lancet Microbe
CRISPR and Genetic Engineering
article

Diagnostics and therapeutics: the CRISPR story continues

The Lancet Microbe
article en

Abstract

The last time The Lancet Microbe featured an Editorial on CRISPR was in November 2020, to mark that year’s Nobel Prize in Chemistry, jointly awarded to Emmanuelle Charpentier and Jennifer A Doudna for their work developing CRISPR-Cas9 genome editing technology.

The Lancet MicrobeVol. 7(4)
Openalex Percentile: Top 8%
CRISPR and Genetic Engineering
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.